Literature DB >> 9472657

HIV-induced IL-6/IL-10 dysregulation of CD4 cells is associated with defective B cell help and autoantibody formation against CD4 cells.

R Weimer1, S Zipperle, V Daniel, R Zimmermann, K Schimpf, G Opelz.   

Abstract

To analyse CD4 cell cytokine secretion and helper/suppressor function at a clonal level we established 446 CD4+ T cell clones (TCC) in four healthy controls, three HIV- haemophilia patients, four CDC II,III and four CDC IV patients. Spontaneous TCC secretion of Th1 cytokines (IL-2, interferon-gamma (IFN-gamma)) and Th2 cytokines (IL-4, IL-6, IL-10) was determined by ELISA. TCC helper and suppressor functions were tested in a pokeweed mitogen (PWM)-stimulated allogeneic co-culture system using a reverse haemolytic plaque assay for assessment of B cell responses. There was a significant association of TCC surface marker expression (Leu-8, CD45RA) with TCC IL-6 secretion in healthy controls (P < 0.01), HIV- patients (P < or = 0.001) and CDC II,III patients (P < or = 0.01) but not in CDC IV patients. Likewise, TCC expression of Leu-8 and CD45RA was significantly associated with TCC suppressor function in healthy controls (P < or = 0.0005) but not in HIV-infected patients. A reduced TCC helper frequency (< or = 10% of TCC) and an enhanced TCC suppressor frequency (> 80% of TCC) were detected only in those HIV-infected patients who showed an excessively increased TCC IL-6 secretion (> 70% of TCC) together with a significantly diminished TCC IL-10 secretion (< or = 10% of TCC). CD4 cell autoantibodies also were found only in patients with this type of cytokine dysregulation. These data indicate that CD4 cell surface markers lose their functional relevance in HIV-infected patients. HIV-induced IL-6/IL-10 dysregulation of CD4+ T cells, i.e. the up-regulation of spontaneous IL-6 and down-regulation of spontaneous IL-10 secretion, appears to be involved in inducing CD4 helper defects and may promote autoantibody formation against CD4 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472657      PMCID: PMC1904842          DOI: 10.1046/j.1365-2249.1998.00429.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  47 in total

1.  Immunophenotyping in a multicenter study: the Transfusion Safety Study experience.

Authors:  M A Fletcher; S P Azen; B Adelsberg; G Gjerset; J Hassett; J Kaplan; J C Niland; T Odom-Maryon; J W Parker; D P Stites
Journal:  Clin Immunol Immunopathol       Date:  1989-07

2.  Autoantibodies against CD4- and CD8-positive T lymphocytes in HIV-infected hemophilia patients.

Authors:  V Daniel; R Weimer; K Schimpf; G Opelz
Journal:  Vox Sang       Date:  1989       Impact factor: 2.144

3.  Reduced production of interleukin 2 and interferon-gamma and enhanced helper activity for IgG synthesis by cloned CD4+ T cells from patients with AIDS.

Authors:  E Maggi; D Macchia; P Parronchi; M Mazzetti; A Ravina; D Milo; S Romagnani
Journal:  Eur J Immunol       Date:  1987-12       Impact factor: 5.532

4.  Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.

Authors:  A Moretta; G Pantaleo; L Moretta; J C Cerottini; M C Mingari
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

5.  Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals.

Authors:  S M Schnittman; H C Lane; J Greenhouse; J S Justement; M Baseler; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Helper and suppressor T-cell function in HIV-infected hemophilia patients.

Authors:  R Weimer; T Schweighoffer; K Schimpf; G Opelz
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

7.  Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones.

Authors:  N Oyaizu; N Chirmule; Y Ohnishi; V S Kalyanaraman; S Pahwa
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  Effect of HIV infection on the frequency of cytokine-secreting cells in human peripheral blood.

Authors:  E Hagiwara; T Sacks; S F Leitman-Klinman; D M Klinman
Journal:  AIDS Res Hum Retroviruses       Date:  1996-01-20       Impact factor: 2.205

9.  B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement.

Authors:  A Amadori; R Zamarchi; M L Veronese; M Panozzo; A Barelli; A Borri; M Sironi; F Colotta; A Mantovani; L Chieco-Bianchi
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

10.  Autoantibodies against CD4 cells are associated with CD4 helper defects in human immunodeficiency virus-infected patients.

Authors:  R Weimer; V Daniel; R Zimmermann; K Schimpf; G Opelz
Journal:  Blood       Date:  1991-01-01       Impact factor: 22.113

View more
  5 in total

1.  Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment.

Authors:  Michaël Imbeault; Michel Ouellet; Katia Giguère; Jonathan Bertin; Dave Bélanger; Geneviève Martin; Michel J Tremblay
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

2.  CD4 depletion in HIV-infected haemophilia patients is associated with rapid clearance of immune complex-coated CD4+ lymphocytes.

Authors:  V Daniel; A Melk; C Süsal; R Weimer; R Zimmermann; A Huth-Kühne; G Opelz
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

3.  Cytokine profiles in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.

Authors:  Brian M Jones; Susan Ss Chiu; Wilfred Hs Wong; Wilina Wl Lim; Yu-Lung Lau
Journal:  J Int AIDS Soc       Date:  2005-05-03       Impact factor: 5.396

Review 4.  B cells in HIV infection and disease.

Authors:  Susan Moir; Anthony S Fauci
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

5.  Cytokine profiles in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.

Authors:  Brian M Jones; Susan S S Chiu; Wilfred H S Wong; Wilina W L Lim; Yu-lung Lau
Journal:  MedGenMed       Date:  2005-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.